» Articles » PMID: 38424439

A DNA Tetrahedron-based Ferroptosis-suppressing Nanoparticle: Superior Delivery of Curcumin and Alleviation of Diabetic Osteoporosis

Overview
Journal Bone Res
Date 2024 Feb 29
PMID 38424439
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetic osteoporosis (DOP) is a significant complication that poses continuous threat to the bone health of patients with diabetes; however, currently, there are no effective treatment strategies. In patients with diabetes, the increased levels of ferroptosis affect the osteogenic commitment and differentiation of bone mesenchymal stem cells (BMSCs), leading to significant skeletal changes. To address this issue, we aimed to target ferroptosis and propose a novel therapeutic approach for the treatment of DOP. We synthesized ferroptosis-suppressing nanoparticles, which could deliver curcumin, a natural compound, to the bone marrow using tetrahedral framework nucleic acid (tFNA). This delivery system demonstrated excellent curcumin bioavailability and stability, as well as synergistic properties with tFNA. Both in vitro and in vivo experiments revealed that nanoparticles could enhance mitochondrial function by activating the nuclear factor E2-related factor 2 (NRF2)/glutathione peroxidase 4 (GPX4) pathway, inhibiting ferroptosis, promoting the osteogenic differentiation of BMSCs in the diabetic microenvironment, reducing trabecular loss, and increasing bone formation. These findings suggest that curcumin-containing DNA tetrahedron-based ferroptosis-suppressing nanoparticles have a promising potential for the treatment of DOP and other ferroptosis-related diseases.

Citing Articles

Current Understanding and Translational Prospects of Tetrahedral Framework Nucleic Acids.

Gu J, Liang J, Tian T, Lin Y JACS Au. 2025; 5(2):486-520.

PMID: 40017737 PMC: 11862954. DOI: 10.1021/jacsau.4c01170.


Targeted inhibition of ferroptosis in bone marrow mesenchymal stem cells by engineered exosomes alleviates bone loss in smoking-related osteoporosis.

Wang Y, Sun L, Dong Z, Zhang T, Wang L, Cao Y Mater Today Bio. 2025; 31:101501.

PMID: 39944529 PMC: 11815285. DOI: 10.1016/j.mtbio.2025.101501.


Theranostic nanoemulsions suppress macrophage-mediated acute inflammation in rats.

Vichare R, Kulahci Y, McCallin R, Zor F, Selek F, Liu L J Nanobiotechnology. 2025; 23(1):80.

PMID: 39905487 PMC: 11792706. DOI: 10.1186/s12951-025-03164-w.


Targeting ferroptosis: opportunities and challenges of mesenchymal stem cell therapy for type 1 diabetes mellitus.

Dai L, Wang Q Stem Cell Res Ther. 2025; 16(1):47.

PMID: 39901210 PMC: 11792594. DOI: 10.1186/s13287-025-04188-7.


Targeting ferroptosis to enhance the efficacy of mesenchymal stem cell-based treatments for intervertebral disc degeneration.

Xu Y, Xu X, Chai R, Wu X Int J Biol Sci. 2025; 21(3):1222-1241.

PMID: 39897051 PMC: 11781166. DOI: 10.7150/ijbs.107021.


References
1.
Zhang Y, Xie X, Ma W, Zhan Y, Mao C, Shao X . Multi-targeted Antisense Oligonucleotide Delivery by a Framework Nucleic Acid for Inhibiting Biofilm Formation and Virulence. Nanomicro Lett. 2021; 12(1):74. PMC: 7770702. DOI: 10.1007/s40820-020-0409-3. View

2.
Sun Y, Cai M, Zhong J, Yang L, Xiao J, Jin F . The long noncoding RNA lnc-ob1 facilitates bone formation by upregulating Osterix in osteoblasts. Nat Metab. 2020; 1(4):485-496. DOI: 10.1038/s42255-019-0053-8. View

3.
Cui S, Liu X, Liu Y, Hu W, Ma K, Huang Q . Autophagosomes Defeat Ferroptosis by Decreasing Generation and Increasing Discharge of Free Fe in Skin Repair Cells to Accelerate Diabetic Wound Healing. Adv Sci (Weinh). 2023; 10(25):e2300414. PMC: 10477857. DOI: 10.1002/advs.202300414. View

4.
Wang Y, Li Y, Gao S, Yu X, Chen Y, Lin Y . Tetrahedral Framework Nucleic Acids Can Alleviate Taurocholate-Induced Severe Acute Pancreatitis and Its Subsequent Multiorgan Injury in Mice. Nano Lett. 2022; 22(4):1759-1768. DOI: 10.1021/acs.nanolett.1c05003. View

5.
Hu X, Wong S, Liang K, Wu T, Wang S, Wang L . Optineurin regulates NRF2-mediated antioxidant response in a mouse model of Paget's disease of bone. Sci Adv. 2023; 9(4):eade6998. PMC: 9882986. DOI: 10.1126/sciadv.ade6998. View